Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 200 Total
ELVN - Enliven Therapeutics Inc - Stock Price Chart
TickerELVN [NASD, RUT]
CompanyEnliven Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap1.00BEPS (ttm)-1.93
P/E-EPS this Y-11.74%
Forward P/E-EPS next Y-21.10%
PEG-EPS past 5Y5.16%
P/S-EPS next 5Y-
P/B3.14EPS Q/Q32.00%
Dividend-Sales Q/Q-
Insider Own42.95%Inst Own57.29%
Insider Trans-15.94%Inst Trans-9.18%
Short Float19.77%EarningsMay 14/a
Analyst Recom1.00Target Price34.67
Avg Volume344.98K52W Range9.80 - 26.00
Enliven Therapeutics, Inc. operates as a clinical stage precision oncology company. It is focused on the discovery and development of next-generation small molecule kinase inhibitors and advancing Enliven's pipeline of precision oncology product candidates. The company was founded by Sam S. Kintz, Joe P. Lyssikatos, and Anish Patel in June 2019 and is headquartered in Boulder, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ORBIMED ADVISORS LLCDirectorMay 16 '24Sale22.141,033,30022,877,262254,814May 20 05:00 PM
Gupta RishiDirectorMay 16 '24Sale22.141,033,30022,877,262254,814May 20 05:03 PM
Heyman Richard A.DirectorMay 16 '24Sale23.741,27030,150135,885May 20 07:46 PM
Patel AnishCHIEF OPERATING OFFICERMay 14 '24Option Exercise2.481,1072,7451,107May 16 07:29 PM
Patel AnishCHIEF OPERATING OFFICERMay 14 '24Sale25.001,10727,6750May 16 07:29 PM
EGHT - 8X8 Inc. - Stock Price Chart
TickerEGHT [NASD, RUT]
Company8X8 Inc.
CountryUSA
IndustrySoftware - Application
Market Cap342.29MEPS (ttm)-0.56
P/E-EPS this Y-14.24%
Forward P/E5.58EPS next Y21.34%
PEG-EPS past 5Y9.88%
P/S0.47EPS next 5Y11.60%
P/B3.35EPS Q/Q-131.18%
Dividend-Sales Q/Q-2.77%
Insider Own2.44%Inst Own91.13%
Insider Trans-4.72%Inst Trans3.96%
Short Float11.86%EarningsMay 08/a
Analyst Recom2.38Target Price4.00
Avg Volume1.14M52W Range2.12 - 4.88
8x8, Inc. engages in the provision of enterprise communication solutions. It offers solutions to the business services, education, financial services, government, healthcare, and manufacturing industries. The company was founded in February 1987 and is headquartered in Campbell, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Middleton HunterChief Product OfficerMay 16 '24Sale2.704221,138435,024May 17 04:38 PM
Kraus KevinChief Financial OfficerMay 16 '24Sale2.704001,078317,112May 17 04:38 PM
Wilson Samuel C.Chief Executive OfficerMay 15 '24Sale2.762,0005,5181,018,288May 17 04:37 PM
Kraus KevinChief Financial OfficerMay 15 '24Sale2.861,0002,860317,512May 17 04:38 PM
Seandel Suzy MChief Accounting OfficerApr 16 '24Sale2.277,25616,436275,172Apr 17 07:45 PM
NKTR - Nektar Therapeutics - Stock Price Chart
TickerNKTR [NASD]
CompanyNektar Therapeutics
CountryUSA
IndustryBiotechnology
Market Cap253.40MEPS (ttm)-0.92
P/E-EPS this Y44.14%
Forward P/E-EPS next Y14.32%
PEG-EPS past 5Y-
P/S2.81EPS next 5Y-7.30%
P/B2.00EPS Q/Q73.95%
Dividend-Sales Q/Q0.21%
Insider Own2.89%Inst Own59.68%
Insider Trans-2.26%Inst Trans-4.28%
Short Float1.48%EarningsMay 09/a
Analyst Recom3.50Target Price1.60
Avg Volume2.60M52W Range0.41 - 1.93
Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology. The firm focuses on using new chemistry approaches to make medicines to treat cancer and autoimmune diseases. The company was founded in 1990 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROBIN HOWARD WPresident & CEOMay 17 '24Sale1.7516,65029,138863,239May 20 09:14 PM
Zalevsky JonathanChief R&D OfficerMay 17 '24Sale1.757,35512,871257,670May 20 09:13 PM
Wilson Mark AndrewChief Legal OfficerMay 17 '24Sale1.756,26010,955230,414May 20 09:12 PM
Deep Track Capital, LP10% OwnerMay 10 '24Sale1.7856,00099,63018,344,000May 13 04:36 PM
ROBIN HOWARD WPresident & CEOFeb 20 '24Sale0.6820,03313,622879,889Feb 22 08:16 PM
MTEM - Molecular Templates Inc - Stock Price Chart
TickerMTEM [NASD]
CompanyMolecular Templates Inc
CountryUSA
IndustryBiotechnology
Market Cap7.63MEPS (ttm)-4.36
P/E-EPS this Y-90.56%
Forward P/E-EPS next Y-11.37%
PEG-EPS past 5Y34.83%
P/S0.24EPS next 5Y3.20%
P/B1.06EPS Q/Q-97.18%
Dividend-Sales Q/Q-69.73%
Insider Own45.12%Inst Own40.53%
Insider Trans9.19%Inst Trans-24.53%
Short Float3.66%EarningsMay 15/a
Analyst Recom1.00Target Price18.00
Avg Volume78.69K52W Range1.16 - 9.45
May-15-24 11:53PM MTEM Stock Earnings: Molecular Templates Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:11PM Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update (GlobeNewswire)
Apr-11-24 01:52PM MTEM Stock Earnings: Molecular Templates Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
Apr-09-24 08:11AM Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patients Observed Through Novel Immuno-oncology Mechanism (GlobeNewswire) -6.57%
Mar-29-24 08:21AM Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update (GlobeNewswire)
Mar-28-24 08:11AM Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement (GlobeNewswire) -5.08%
Mar-04-24 08:11AM Molecular Templates, Inc. Provides Interim Update (GlobeNewswire)
Feb-08-24 05:55PM Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Nov-13-23 04:11PM Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business Update (GlobeNewswire)
Nov-02-23 04:11PM Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid Tumors (GlobeNewswire)
Molecular Templates, Inc. engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. It utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. The company was founded by Eric E. Poma, Jean Gariepy, and Leigh Revers in 2001 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BIOTECH TARGET N V10% OwnerApr 02 '24Buy2.35250,000587,5001,279,820Apr 04 08:13 PM
BIOTECH TARGET N V10% OwnerJul 17 '23Buy0.474,255,3192,000,00015,447,322Jul 19 03:14 PM
LSB - LakeShore Biopharma Co Ltd. - Stock Price Chart
TickerLSB [NASD]
CompanyLakeShore Biopharma Co Ltd.
CountryChina
IndustryBiotechnology
Market Cap175.15MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.29EPS Q/Q-215.70%
Dividend-Sales Q/Q-
Insider Own89.57%Inst Own2.71%
Insider Trans0.00%Inst Trans0.17%
Short Float0.29%EarningsApr 19/b
Analyst Recom1.00Target Price5.17
Avg Volume168.78K52W Range0.35 - 1.78
LakeShore Biopharma Co., Ltd. engages in discovering, developing, manufacturing, and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on developing PIKA technology platform. It operates through the People's Republic of China and Other Countries or Regions. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in Beijing, China.
XYLO - Xylo Technologies Ltd. ADR - Stock Price Chart
TickerXYLO [NASD]
CompanyXylo Technologies Ltd. ADR
CountryIsrael
IndustryMedical Devices
Market Cap3.74MEPS (ttm)-9.62
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-32.16%
P/S0.04EPS next 5Y-
P/B0.16EPS Q/Q-1104.85%
Dividend-Sales Q/Q-36.36%
Insider Own0.06%Inst Own0.21%
Insider Trans0.00%Inst Trans-44.19%
Short Float0.26%Earnings-
Analyst Recom1.00Target Price1350.00
Avg Volume72.30K52W Range1.50 - 6.91
Xylo Technologies Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm focuses on medical-related devices and products on internet and other online-related technologies, and vehicle and wireless charging activities. It operates through the following segments: Corporate, E-Commerce, Online, and Others. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Tel Aviv, Israel.
SUGP - SU Group Holdings Ltd. - Stock Price Chart
TickerSUGP [NASD]
CompanySU Group Holdings Ltd.
CountryHong Kong
IndustrySecurity & Protection Services
Market Cap29.68MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own72.91%Inst Own0.00%
Insider Trans0.00%Inst Trans-
Short Float0.33%Earnings-
Analyst Recom-Target Price-
Avg Volume59.45K52W Range1.83 - 5.86
SU Group Holdings Ltd. engages in the provision of integrated security-related services. Its services include threat detection, traffic and vehicle control, pedestrian access control, ELV system, security personnel, and vocational training. It operates through the Security-related Engineering Services, and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.
DRIO - DarioHealth Corp - Stock Price Chart
TickerDRIO [NASD]
CompanyDarioHealth Corp
CountryUSA
IndustryHealth Information Services
Market Cap44.13MEPS (ttm)-1.71
P/E-EPS this Y50.95%
Forward P/E-EPS next Y69.89%
PEG-EPS past 5Y34.16%
P/S2.32EPS next 5Y-
P/B0.56EPS Q/Q55.46%
Dividend-Sales Q/Q-18.51%
Insider Own17.02%Inst Own29.95%
Insider Trans0.00%Inst Trans-10.57%
Short Float5.90%EarningsMay 15/b
Analyst Recom1.00Target Price5.67
Avg Volume139.70K52W Range0.68 - 4.58
DarioHealth Corp. is a digital health company which offers a user-centric and multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. DarioHealth serves customers globally. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in New York, NY.
WISA - WiSA Technologies Inc - Stock Price Chart
TickerWISA [NASD]
CompanyWiSA Technologies Inc
CountryUSA
IndustrySemiconductors
Market Cap9.39MEPS (ttm)-387.73
P/E-EPS this Y99.23%
Forward P/E-EPS next Y31.77%
PEG-EPS past 5Y82.60%
P/S5.02EPS next 5Y-
P/B-EPS Q/Q93.29%
Dividend-Sales Q/Q-45.63%
Insider Own7.39%Inst Own3.22%
Insider Trans-2.87%Inst Trans-6.04%
Short Float17.06%EarningsMay 21/b
Analyst Recom2.00Target Price18.00
Avg Volume6.57M52W Range1.66 - 306.00
WiSA Technologies, Inc. engages in the manufacturing of modules which wirelessly transmit and receive audio directly to speakers. Its products include Summit TX-SD, Summit RX-SD, TX Dev Kit, RX Dev Kit, 30 Watt Amp, and DAC board. The company was founded on July 23, 2010 and is headquartered in Beaverton, OR.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MOYER BRETTSee RemarksDec 18 '23Sale0.13801074,509Dec 19 04:02 PM
WILLIAMS GARYSee RemarksDec 18 '23Sale0.1316248,931Dec 19 04:02 PM
MOYER BRETTSee RemarksNov 28 '23Sale0.126,15977074,589Nov 30 04:01 PM
WILLIAMS GARYSee RemarksNov 28 '23Sale0.123,94049248,947Nov 30 04:02 PM
AMC - AMC Entertainment Holdings Inc - Stock Price Chart
TickerAMC [NYSE]
CompanyAMC Entertainment Holdings Inc
CountryUSA
IndustryEntertainment
Market Cap1.33BEPS (ttm)-1.37
P/E-EPS this Y33.71%
Forward P/E-EPS next Y59.79%
PEG-EPS past 5Y-
P/S0.28EPS next 5Y-
P/B-EPS Q/Q-262.14%
Dividend-Sales Q/Q-0.31%
Insider Own0.34%Inst Own29.25%
Insider Trans0.00%Inst Trans-9.10%
Short Float19.26%EarningsMay 08/a
Analyst Recom3.86Target Price4.44
Avg Volume48.50M52W Range2.38 - 54.97
AMC Entertainment Holdings, Inc. engages in the theatrical exhibition business through its subsidiaries. It operates through the U.S. Markets and International Markets segments. The U.S. Markets segment is involved in owning, leasing, or operating theaters and screens in the U.S. The International Markets segment focuses on owning, leasing, or operating theaters and screens in the United Kingdom, Germany, Spain, Italy, Ireland, Portugal, Sweden, Finland, Norway, Denmark, and Saudi Arabia. The company was founded by Barney Dubinsky, Maurice Durwood and Edward Durwood in 1920 and is headquartered in Leawood, KS.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CHAVARRIA CARLA CSVP, Chief HR OfficerJan 02 '24Option Exercise0.0010,107057,096Jan 10 04:34 PM
FRANK ELIZABETH FEVP CHIEF PROGRAM OFFICERJan 02 '24Option Exercise0.0013,358035,376Jan 10 05:18 PM
ELLIS DANIEL EEVP, Chief Ops & Dev OfficerJan 02 '24Option Exercise0.0011,880030,185Jan 10 05:26 PM
CONNOR KEVIN MSVP GENERAL COUNSEL & SECJan 02 '24Option Exercise0.0010,543027,857Jan 10 05:32 PM
ARON ADAM MChairman, President & CEOJan 02 '24Option Exercise0.00126,3280492,664Jan 10 05:42 PM
15678910111213141520